Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease

被引:84
|
作者
Fukuda, K
Vishnuvardhan, D
Sekiya, S
Hwang, J
Kakiuchi, N
Kazunari, T
Shimotohno, K
Kumar, PKR
Nishikawa, S [1 ]
机构
[1] MITI, AIST, Natl Inst Biosci & Human Technol, Tsukuba Sci City 3058566, Japan
[2] Univ Tsukuba, Inst Appl Biochem, Tsukuba Sci City, Japan
[3] MITI, AIST, Natl Inst Adv Interdisciplinary Res, Tsukuba Sci City, Japan
[4] Kyoto Univ, Inst Virus Res, Kyoto, Japan
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2000年 / 267卷 / 12期
关键词
HCV; RNA aptamer; SELEX; NS3 serine protease;
D O I
10.1046/j.1432-1327.2000.01400.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nonstructural protein 3 (NS3) from hepatitis C virus (HCV) is a serine protease that provides an essential function in maturation of the virus by cleaving the nonstructural regions of the viral polyprotein. The goal of this work was to isolate RNA aptamers that bind specifically to the NS3 protease active site in the truncated polypeptide Delta NS3. RNA aptamers were selected in vitro by systematic evolution of ligands by exponential enrichment (SELEX). The RNA pool for SELEX had a 30-nucleotide randomized core region. After nine selection cycles, a pool of Delta NS3-specific RNA aptamers were obtained. This RNA pool included 45 clones that divided into three main classes (G9-I, II and III). These classes include the conserved sequence GA(A/U)UGGGAC. These aptamers bind to Delta NS3 with a binding constant of about 10 nM and inhibit approximately 90% of the protease activity of Delta NS3 and MBP-NS3 (full-length of NS3 fused with maltose binding protein). In addition, these aptamers inhibited approximately 70% of the MBP-NS3 protease activity in the presence of the NS4A peptide P41. G9-I aptamer appeared to be a noncompetitive inhibitor for Delta NS3 with a K-i approximate to 100 nM in the presence of P41. These results suggest that the pool of selected aptamers have potential as anti-HCV compounds. Mutational analysis of the G9-I aptamer demonstrated that the sequences required for protease inhibition are in stem I, stem III and loop III of the aptamer. These regions include the conserved sequence GA(A/U)UGGGAC.
引用
收藏
页码:3685 / 3694
页数:10
相关论文
共 50 条
  • [21] RNA aptamers targeted to domain II of hepatitis C virus IRES that bind to its apical loop region
    Kikuchi, K
    Umehara, T
    Fukuda, K
    Hwang, J
    Kuno, A
    Hasegawa, T
    Nishikawa, S
    JOURNAL OF BIOCHEMISTRY, 2003, 133 (03) : 263 - 270
  • [22] Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase
    Suzuki, Ryosuke
    Matsuda, Mami
    Shimoike, Takashi
    Watashi, Koichi
    Aizaki, Hideki
    Kato, Takanobu
    Suzuki, Tetsuro
    Muramatsu, Masamichi
    Wakita, Takaji
    VIROLOGY, 2019, 529 : 226 - 233
  • [23] In vitro selection of RNA aptamers that bind the RNA-dependent RNA polymerase of hepatitis C virus: A possible role of GC-rich RNA motifs in NS5B binding
    Kanamori, Hiroshi
    Yuhashi, Kazuhito
    Uchiyama, Yasutoshi
    Kodama, Tatsuhiko
    Ohnishi, Shin
    VIROLOGY, 2009, 388 (01) : 91 - 102
  • [25] Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts
    Aizaki, H
    Lee, KJ
    Sung, VMH
    Ishiko, H
    Lai, MMC
    VIROLOGY, 2004, 324 (02) : 450 - 461
  • [26] Reducing the incidence of hepatocellular carcinoma due to hepatitis C virus infection by detecting resistance-associated substitutions in hepatitis C virus NS5A nonstructural protein
    RozainaneeMohd Zain
    Nurul Asshikin Ruslan
    Sairulahkma Awang
    Muhammad Adib Abd Wahab
    Ravindran Thayan
    Cancer Biology & Medicine, 2018, 15(S1) (S1) : 7 - 7
  • [27] Chip-based detection of hepatitis C virus using RNA aptamers that specifically bind to HCV core antigen
    Lee, Seram
    Kim, Young Sook
    Jo, Minjung
    Jin, Moonsoo
    Lee, Dong-ki
    Kim, Soyoun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 358 (01) : 47 - 52
  • [28] Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)
    McPhee, Fiona
    Sheaffer, Amy K.
    Friborg, Jacques
    Hernandez, Dennis
    Falk, Paul
    Zhai, Guangzhi
    Levine, Steven
    Chaniewski, Susan
    Yu, Fei
    Barry, Diana
    Chen, Chaoqun
    Lee, Min S.
    Mosure, Kathy
    Sun, Li-Qiang
    Sinz, Michael
    Meanwell, Nicholas A.
    Colonno, Richard J.
    Knipe, Jay
    Scola, Paul
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (10) : 5387 - 5396
  • [29] Molecular characterization of Hepatitis C virus 3a in Peshawar
    Gul, Amina
    Zahid, Nabeela
    Ahmed, Jawad
    Zahir, Fazli
    Khan, Imtiaz Ali
    Ali, Ijaz
    BMC INFECTIOUS DISEASES, 2016, 16
  • [30] Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+response in patients with chronic hepatitis C
    López-Labrador, FX
    He, XS
    Berenguer, M
    Cheung, RC
    González-Candelas, F
    Wright, TL
    Greenberg, HB
    JOURNAL OF MEDICAL VIROLOGY, 2004, 72 (04) : 575 - 585